• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Association between the FCGR3A V158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients.

作者信息

Morales-Lara M J, Conesa-Zamora P, García-Simón M S, Pedrero F, Santaclara V, Perez-Guillermo M, Soriano-Navarro E

出版信息

Scand J Rheumatol. 2010 Nov;39(6):518-20. doi: 10.3109/03009741003781969. Epub 2010 Jun 21.

DOI:10.3109/03009741003781969
PMID:20560817
Abstract
摘要

相似文献

1
Association between the FCGR3A V158F polymorphism and the clinical response to infliximab in rheumatoid arthritis and spondyloarthritis patients.类风湿关节炎和脊柱关节炎患者中FCGR3A基因V158F多态性与英夫利昔单抗临床反应的关联
Scand J Rheumatol. 2010 Nov;39(6):518-20. doi: 10.3109/03009741003781969. Epub 2010 Jun 21.
2
Influence of variants of Fc gamma receptors IIA and IIIA on the American College of Rheumatology and European League Against Rheumatism responses to anti-tumour necrosis factor alpha therapy in rheumatoid arthritis.Fcγ受体IIA和IIIA变体对美国风湿病学会和欧洲抗风湿病联盟制定的类风湿关节炎抗肿瘤坏死因子α治疗反应的影响
Ann Rheum Dis. 2009 Oct;68(10):1547-52. doi: 10.1136/ard.2008.096982. Epub 2008 Oct 17.
3
The effect of infliximab and timing of vaccination on the humoral response to influenza vaccination in patients with rheumatoid arthritis and ankylosing spondylitis.英夫利昔单抗的作用及接种时机对类风湿关节炎和强直性脊柱炎患者流感疫苗接种后体液免疫应答的影响。
Semin Arthritis Rheum. 2010 Jun;39(6):442-7. doi: 10.1016/j.semarthrit.2008.12.002. Epub 2009 Feb 26.
4
A polymorphism in the gene encoding the Fcgamma IIIA receptor is a possible genetic marker to predict the primary response to infliximab in Japanese patients with rheumatoid arthritis.编码FcγIIIA受体的基因中的一种多态性可能是预测日本类风湿性关节炎患者对英夫利昔单抗初始反应的一种遗传标记。
Ann Rheum Dis. 2008 Dec;67(12):1791-2. doi: 10.1136/ard.2007.086892.
5
Fcgamma receptor type IIIA genotype and response to tumor necrosis factor alpha-blocking agents in patients with rheumatoid arthritis.类风湿关节炎患者中Fcγ受体IIIA基因型与对肿瘤坏死因子α阻断剂的反应
Arthritis Rheum. 2007 Feb;56(2):448-52. doi: 10.1002/art.22390.
6
Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: a role for scintigraphy with 99mTc-infliximab.英夫利昔单抗关节腔内注射成功治疗一名脊柱关节病患者的难治性膝关节单关节炎：99mTc-英夫利昔单抗闪烁扫描的作用
Arthritis Rheum. 2005 Apr;52(4):1224-6. doi: 10.1002/art.20979.
7
Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.类风湿关节炎或脊柱关节病患者接受英夫利昔单抗治疗后的抗核抗体
Arthritis Rheum. 2003 Apr;48(4):1015-23. doi: 10.1002/art.10876.
8
Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitis.英夫利昔单抗治疗对类风湿关节炎和强直性脊柱炎患者胰岛素抵抗的影响。
Ann Rheum Dis. 2005 May;64(5):765-6. doi: 10.1136/ard.2004.026534. Epub 2004 Sep 30.
9
Efficacy and safety of infliximab in patients with ankylosing spondylitis over a two-year period.英夫利昔单抗治疗强直性脊柱炎患者两年的疗效与安全性。
Arthritis Rheum. 2008 Sep 15;59(9):1270-8. doi: 10.1002/art.24001.
10
[Suspected cases of severe side effects after infliximab (Remicade) in Germany].
Med Klin (Munich). 2003 Aug 15;98(8):428. doi: 10.1007/s00063-003-1281-x.

引用本文的文献

1
The Association between Genetics and Response to Treatment with Biologics in Patients with Psoriasis, Psoriatic Arthritis, Rheumatoid Arthritis, and Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis.遗传因素与生物制剂治疗银屑病、银屑病关节炎、类风湿关节炎和炎症性肠病患者反应的相关性：系统评价和荟萃分析。
Int J Mol Sci. 2024 May 26;25(11):5793. doi: 10.3390/ijms25115793.
2
Genetic variability of three common NK and γδ T cell receptor genes (FCγ3R, NCR3, and DNAM-1) and their role in Polish patients with rheumatoid arthritis and ankylosing spondylitis.三种常见 NK 和 γδ T 细胞受体基因（FCγ3R、NCR3 和 DNAM-1）的遗传变异及其在波兰类风湿关节炎和强直性脊柱炎患者中的作用。
Immunol Res. 2024 Aug;72(4):614-625. doi: 10.1007/s12026-024-09488-3. Epub 2024 May 7.
3
Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?遗传学是否有助于预测银屑病关节炎中 TNF 抑制剂的反应？
Pharmacogenomics J. 2023 Jan;23(1):1-7. doi: 10.1038/s41397-022-00290-8. Epub 2022 Oct 15.
4
Spondyloarthritis: How far are we from precision medicine?脊柱关节炎：我们距离精准医疗还有多远？
Front Med (Lausanne). 2022 Sep 8;9:988532. doi: 10.3389/fmed.2022.988532. eCollection 2022.
5
Gene Ontology Analysis Highlights Biological Processes Influencing Non-Response to Anti-TNF Therapy in Rheumatoid Arthritis.基因本体分析突显影响类风湿关节炎抗TNF治疗无反应的生物学过程。
Biomedicines. 2022 Jul 27;10(8):1808. doi: 10.3390/biomedicines10081808.
6
Toward Overcoming Treatment Failure in Rheumatoid Arthritis.克服类风湿关节炎治疗失败
Front Immunol. 2021 Dec 23;12:755844. doi: 10.3389/fimmu.2021.755844. eCollection 2021.
7
The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review.脊柱关节炎中药物反应的遗传贡献：一项系统文献综述
Front Genet. 2021 Jul 20;12:703911. doi: 10.3389/fgene.2021.703911. eCollection 2021.
8
Influence of the rs1801274 and rs396991 Polymorphisms on Response to Abatacept in Patients with Rheumatoid Arthritis.rs1801274和rs396991基因多态性对类风湿关节炎患者使用阿巴西普疗效的影响。
J Pers Med. 2021 Jun 18;11(6):573. doi: 10.3390/jpm11060573.
9
Genetic and clinical markers for predicting treatment responsiveness in rheumatoid arthritis.预测类风湿关节炎治疗反应的遗传和临床标志物。
Front Med. 2019 Aug;13(4):411-419. doi: 10.1007/s11684-018-0659-3. Epub 2019 Jan 12.
10
A Polymorphism Predicts Anti-drug Antibodies in Chronic Inflammatory Bowel Disease Patients Treated With Anti-TNF.抗 TNF 治疗慢性炎症性肠病患者的药物抗体与一种多态性相关。
Int J Med Sci. 2018 Jan 1;15(1):10-15. doi: 10.7150/ijms.22812. eCollection 2018.